Pharmaceuticals, Biotechnology and Life Sciences
REYKJAVIK, Iceland–(BUSINESS WIRE)–Biopharmaceutical company Alvotech announced today that Abu Dhabi-based investment company, Yas Holding, has acquired a 2.5% stake in…
Agreement to jointly commercialise the new diabetic kidney disease (DKD) indication for INVOKANA® (canagliflozin) in the US Only diabetes treatment…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational RNA interference (RNAi) therapeutics,…
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will issue a press release on its…
DUBLIN–(BUSINESS WIRE)–The “Respiratory Syncytial Virus: Opportunity Analysis and Forecasts to 2028” report has been added to ResearchAndMarkets.com’s offering. The burden…
DUBLIN–(BUSINESS WIRE)–The “Philippines Nutraceuticals Market Outlook to 2022-Composite Herbal Dietary Ingredients, Ginseng, Garlic and Ginkgo Biloba Based Herbal Supplements will…
DUBLIN–(BUSINESS WIRE)–The “Single Cell Genomics Markets – Forecasts by End User & Technology – With Executive & Consultant Guides, Including…
EDMONTON, Alberta–(BUSINESS WIRE)–The BioAlberta Board of Directors announced today that Mr. Robb Stoddard has been appointed BioAlberta’s new President and…
Current NATESTO® supply to the United States remains unaffected TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) today provided an update on…
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve…